Tue, August 6, 2024
[ 12:00 AM ] - WOPRAI
Wed, July 24, 2024
[ 12:00 AM ] - WOPRAI
Tue, April 16, 2024
[ 12:00 AM ] - WOPRAI
Wed, October 11, 2023
[ 12:00 AM ] - WOPRAI
Mon, July 10, 2023
[ 12:00 AM ] - WOPRAI
Fri, February 10, 2023
[ 12:00 AM ] - WOPRAI
Wed, February 8, 2023
[ 12:00 AM ] - WOPRAI
Thu, February 2, 2023
[ 12:00 AM ] - WOPRAI
Tue, January 17, 2023
[ 12:00 AM ] - WOPRAI
Thu, December 22, 2022
[ 12:00 AM ] - WOPRAI
Thu, November 17, 2022
[ 12:00 AM ] - WOPRAI
Fri, September 30, 2022
[ 12:00 AM ] - WOPRAI
Mon, May 23, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, April 30, 2021
[ 12:00 AM ] - WOPRAI
Wed, March 10, 2021
[ 12:00 AM ] - WOPRAI
Fri, February 26, 2021
[ 12:00 AM ] - WOPRAI
Thu, January 28, 2021
[ 12:00 AM ] - WOPRAI
Fri, November 13, 2020
[ 12:00 AM ] - WOPRAI
Thu, August 20, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, May 11, 2020
[ 12:00 AM ] - WOPRAI
Thu, April 2, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, April 1, 2020
[ 12:00 AM ] - WOPRAI
Fri, February 14, 2020
David Risinger Downgraded (TBPH) to Hold and Decreased Target to $10 on, Aug 6th, 2024
David Risinger of Leerink Partners, Downgraded "Theravance Biopharma, Inc." (TBPH) to Hold and Decreased Target from $15 to $10 on, Aug 6th, 2024.
David has made no other calls on TBPH in the last 4 months.
There is 1 other peer that has a rating on TBPH. Out of the 1 peers that are also analyzing TBPH, 0 agree with David's Rating of Hold.
This is the rating of the analyst that currently disagrees with David
- Julian Harrison of "BTIG" Initiated at Strong Buy and Held Target at $21 on, Friday, April 12th, 2024
Contributing Sources